Adverse effect
hideIn medicine, an adverse effect is a harmful and undesired effect resulting from a medication or other intervention such as surgery. An adverse effect may be termed a "side effect", when judged to be secondary to a main or therapeutic effect, and may result from an unsuitable or incorrect dosage or procedure, which could be due to medical error. Adverse effects are sometimes referred to as "iatrogenic" because they are generated by a physician/treatment. Some adverse effects only occur only when starting, increasing or discontinuing a treatment. Using a drug or other medical intervention which is contraindicated may increase the risk of adverse effects. Adverse effects may cause medical complications of a disease or procedure and negatively affect its prognosis. They may also lead to non-compliance with a treatment regimen.
The harmful outcome is usually indicated by some result such as morbidity, mortality, alteration in body weight, levels of enzymes, loss of function, or as a pathological change detected at the microscopic, macroscopic or physiological level. It may also be indicated by symptoms reported by a patient. Adverse effects may cause a reversible or irreversible change, including an increase or decrease in the susceptibility of the individual to other chemicals, foods, or procedures, such as drug interactions.
In clinical trials, a distinction is made between adverse events (AEs) and serious adverse events (SAEs). Generally, any event which causes death, permanent damage, birth defects, or requires hospitalization is considered an SAE. The results of these trials are often included in the labeling of the medication to provide information both for patients and the prescribing physicians.
For more information about Adverse effect, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with side effects
Study confirms that cannabis is beneficial for multiple sclerosis
Medicine & Health / Neuroscience
Dec 04, 2009 |
5 / 5 (20) |
0
Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spa ...
Study points to new uses, unexpected side effects of already existing drugs
Nov 04, 2009 |
5 / 5 (3) |
0
Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases ...
New mechanisms of action found for drugs used to treat anxiety disorders
Jun 23, 2009 |
4 / 5 (5) |
0
(PhysOrg.com) -- In the course of his or her life, every seventh German will develop an anxiety disorder that will require treatment. Standard anti-anxiety medications (anxiolytics) are based on the benzodiazepine ...
Grapefruit juice boosts drug's anti-cancer effects
Apr 20, 2009 |
4.6 / 5 (7) |
1
In a small, early clinical trial, researchers at the University of Chicago Medical Center have found that combining eight ounces of grapefruit juice with the drug rapamycin can increase drug levels, allowing lower doses of ...
Licorice compound offers new cancer prevention strategy
Mar 23, 2009 |
4.7 / 5 (3) |
1
A chemical component of licorice may offer a new approach to preventing colorectal cancer without the adverse side effects of other preventive therapies, Vanderbilt University Medical Center researchers report.
Researchers Isolate Protein Domain Linked to Tumor Progression
Feb 17, 2009 |
4.5 / 5 (2) |
0
(PhysOrg.com) -- When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix ...
What causes motor complications of Parkinson's treatment?
Jan 29, 2009 |
not rated yet |
0
People with Parkinson's disease commonly suffer a slowing or freezing of movement caused by the death of neurons that make dopamine, a key chemical that allows brain cells to send and receive messages essential ...
Scientists unravel structure of key breast cancer target enzyme
Jan 07, 2009 |
5 / 5 (2) |
0
The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward Medical ...
Researchers find clue to safer obesity drugs
Nov 25, 2008 |
5 / 5 (1) |
0
(PhysOrg.com) -- Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern ...
New platinum-phosphate compounds kill ovarian cancer cells
Nov 19, 2008 |
3.8 / 5 (4) |
0
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the ...
An advance on new generations of chemotherapy and antiviral drugs
Sep 08, 2008 |
4 / 5 (1) |
0
Researchers are describing progress toward developing a new generation of chemotherapy agents that target and block uncontrolled DNA replication — a hallmark of cancer, viral infections, and other diseases ...
Looking beyond the drug receptor for clues to drug effectiveness
Aug 25, 2008 |
3 / 5 (2) |
0
Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes ...
FDA approves first drug for Huntington's disease
Medicine & Health / Medications
Aug 16, 2008 |
4.5 / 5 (8) |
0
The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. ...
New treatment for advanced prostate cancer
Jul 29, 2008 |
4.6 / 5 (17) |
0
Researchers at the University of Adelaide have developed a novel approach to treating advanced prostate cancer that could be more effective with fewer side effects.
Teaching old drugs new tricks
Biology /
Jul 10, 2008 |
5 / 5 (1) |
0
Researchers from the European Molecular Biology Laboratory discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs ...
